Sanofi Consumer Healthcare India profit and loss

Latest FY26

Revenue: ₹878cr+21.2% on FY25
EBITDA: ₹309cr+14.2% on FY25
Net profit: ₹240cr+32.7% on FY25
EPS: ₹104.27+32.7% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Dec 2025	FY25Dec 2024

Expenses
	979	878	725
	20.9	18.4	13.0
	1,000	897	738
	178	161	127
	51.8	70.2	42.1
	15.1	−0.8	16.6
	131	129	103
	1.7	2.0	3.9
	13.0	11.7	4.5
	234	211	165
	624	583	462
	370	309	271
	357	297	266
Profit
	376	314	275
	0.0	6.6	−28.4
	376	320	247
	98.2	82.0	69.6
	−2.1	−1.8	−3.8
	96.1	80.2	65.8
	280	240	181
	280	240	181
	−2.2	−1.4	−1.4
	278	239	180
Per share
	₹121.44	₹104.27	₹78.59
	₹121.44	₹104.27	₹0.00
Other comprehensive income — detail
	—	−1.4	—
	—	−1.9	−1.9
	—	−0.5	—
	—	—	−0.5
Per share — as-filed variants
	₹121.44	₹104.27	₹78.59
	₹121.44	₹104.27	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	734	648	538
	75.0%	73.8%	74.3%
Adjusted (ex-exceptional items) — derived
	376	314	275
	0.0	6.6	−28.4
	280	235	202
	₹121.44	₹102.12	₹87.63

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SANOFICONR₹3,322.80

Sanofi Consumer Healthcare India Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersPGHL SANOFI SENORES INNOVACAP MOREPENLAB IOLCP FDC ASTRAZENMcap ₹7,642 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/12/2024	FY26 31/12/2025	Last 12M 30/09/2026
Revenue from Operations	724.5	878.4	979.0
Other Income	13.0	18.4	20.9
Total Income	737.5	896.8	999.9
Expenses
+ Cost of Materials Consumed	127.4	160.7	178.3
+ Purchases of Stock-in-Trade	42.1	70.2	51.8
+ Changes in Inventories	16.6	-0.8	15.1
+ Employee Benefit Expense	102.7	128.8	130.6
+ Finance Costs	3.9	2.0	1.7
+ Depreciation & Amortisation	4.5	11.7	13.0
+ Other Expenses	165.1	210.5	233.6
Total Expenses	462.3	583.1	624.1
EBITDA	270.6	309.0	369.6
EBIT	266.1	297.3	356.6
Profit
PBT before Exceptional Items	275.2	313.7	375.8
+ Exceptional Items	-28.4	6.6	0.0
Pretax Income	246.8	320.3	375.8
+ Current Tax	69.6	82.0	98.2
+ Deferred Tax	-3.8	-1.8	-2.1
Tax Expense	65.8	80.2	96.1
Net Income	181.0	240.1	279.7
+ Net Income — Continuing Ops	181.0	240.1	279.7
+ Other Comprehensive Income	-1.4	-1.4	-2.2
Total Comprehensive Income	179.6	238.7	277.5
Per Share
Basic EPS	78.59	104.27	121.44
Diluted EPS	0.00	104.27	121.44
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	-1.4	—
+ Items NOT to be Reclassified to P&L	-1.9	-1.9	—
+ Tax on Items NOT to be Reclassified	—	-0.5	—
+ Tax on Items NOT to be Reclassified — alt tag	-0.5	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	78.59	104.27	121.44
Diluted EPS — Continuing Operations	0.00	104.27	121.44
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	538.4	648.3	733.8
Gross Margin %	74.31	73.80	74.95
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	275.2	313.7	375.8
− Exceptional Items (reconciliation)	-28.4	6.6	0.0
Net Income Adj (tax-effected)	201.8	235.2	279.7
EPS Adj	87.63	102.12	121.44
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00
Paid Up Equity Capital	23.0	23.0	23.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.